Cargando…

The effects of maternal depression and maternal selective serotonin reuptake inhibitor exposure on offspring

It has been estimated that 20% of pregnant women suffer from depression and it is well-documented that maternal depression can have long-lasting effects on the child. Currently, common treatment for maternal depression has been the selective serotonin reuptake inhibitor medications (SSRIs) which are...

Descripción completa

Detalles Bibliográficos
Autores principales:	Olivier, J. D. A., Åkerud, H., Kaihola, H., Pawluski, J. L., Skalkidou, A., Högberg, U., Sundström-Poromaa, I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2013
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659337/ https://www.ncbi.nlm.nih.gov/pubmed/23734100 http://dx.doi.org/10.3389/fncel.2013.00073

Ejemplares similares

The Effect of Antenatal Depression and Selective Serotonin Reuptake Inhibitor Treatment on Nerve Growth Factor Signaling in Human Placenta
por: Kaihola, Helena, et al.
Publicado: (2015)

The effects of antenatal depression and antidepressant treatment on placental gene expression
por: Olivier, Jocelien D. A., et al.
Publicado: (2015)

Placental glucocorticoid receptors are not affected by maternal depression or SSRI treatment
por: Edvinsson, Åsa, et al.
Publicado: (2020)

Maternal and infant genetic variants, maternal periconceptional use of selective serotonin reuptake inhibitors, and risk of congenital heart defects in offspring: population based study
por: Nembhard, Wendy N, et al.
Publicado: (2017)

Maternal body mass index moderates antenatal depression effects on infant birthweight
por: Petursdottir Maack, Heidrun, et al.
Publicado: (2019)

Effects of Fluoxetine on Human Embryo Development
por: Kaihola, Helena, et al.
Publicado: (2016)

RAVE DRUG (ECSTASY) AND SELECTIVE SEROTONIN REUPTAKE INHIBITOR ANTI-DEPRESSANTS
por: Singh, A.N., et al.
Publicado: (2000)

Maternal Serotonin Reuptake Inhibitor Antidepressants Have Acute Effects on Fetal Heart Rate Variability in Late Gestation
por: Campbell, Kayleigh S. J., et al.
Publicado: (2021)

Maternal and female fetal testosterone levels are associated with maternal age and gestational weight gain
por: Kallak, Theodora Kunovac, et al.
Publicado: (2017)

Sentiment Analysis of Online Reviews for Selective Serotonin Reuptake Inhibitors and Serotonin–Norepinephrine Reuptake Inhibitors
por: Compagner, Chad, et al.
Publicado: (2021)

Prenatal exposure to serotonin reuptake inhibitors: a case report
por: Marsella, Maria, et al.
Publicado: (2010)

Improvement of social adaptation in depression with serotonin and norepinephrine reuptake inhibitors
por: Briley, Mike, et al.
Publicado: (2010)

Differences in secretome in culture media when comparing blastocysts and arrested embryos using multiplex proximity assay
por: Lindgren, Karin E., et al.
Publicado: (2018)

The effect of antenatal depression and antidepressant treatment on placental tissue: a protein-validated gene expression study
por: Edvinsson, Åsa, et al.
Publicado: (2019)

Effects of Selective Serotonin Reuptake Inhibitors on Interregional Relation of Serotonin Transporter Availability in Major Depression
por: James, Gregory M., et al.
Publicado: (2017)

Rapid response to selective serotonin reuptake inhibitors in post-COVID depression
por: Mazza, Mario Gennaro, et al.
Publicado: (2022)

Sex differences in depression during pregnancy and the postpartum period
por: Sundström Poromaa, Inger, et al.
Publicado: (2016)

Depression and the Use of Selective Serotonin Reuptake Inhibitors in Patients with Acute Intracerebral Hemorrhage
por: Syed, Maryam J, et al.
Publicado: (2019)

Maternal occupational exposure and oral clefts in offspring
por: Spinder, Nynke, et al.
Publicado: (2017)

Associations between maternal depressive symptoms and selective serotonin reuptake inhibitor antidepressant treatment on internalising and anxiety behaviours in children: 12-year longitudinal study
por: Hutchison, Sarah M., et al.
Publicado: (2023)

Serotonin transporter gene polymorphism and treatment response to serotonin reuptake inhibitor (escitalopram) in depression: An open pilot study
por: Margoob, Mushtaq A., et al.
Publicado: (2008)

The Risk of Congenital Heart Anomalies Following Prenatal Exposure to Serotonin Reuptake Inhibitors—Is Pharmacogenetics the Key?
por: Daud, Aizati N. A., et al.
Publicado: (2016)

A meta-analysis of effects of selective serotonin reuptake inhibitors on blood pressure in depression treatment: outcomes from placebo and serotonin and noradrenaline reuptake inhibitor controlled trials
por: Zhong, Zhuoyuan, et al.
Publicado: (2017)

Clinical pharmacology of serotonin selective reuptake inhibitors /
por: Preskorn, Sheldon
Publicado: (1996)

Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia
por: Welsch, Patrick, et al.
Publicado: (2018)

Selective serotonin reuptake inhibitors and Alzheimer’s disease
por: Mdawar, Bernadette, et al.
Publicado: (2019)

Effects of Selective Serotonin Reuptake Inhibitor Treatment on Ovarian Reserves in Patients with Depression
por: Gök, Soner, et al.
Publicado: (2023)

A randomised, double-blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin–noradrenaline reuptake inhibitor treatment switched to vortioxetine or agomelatine†
por: Montgomery, Stuart A, et al.
Publicado: (2014)

Effects of selective serotonin reuptake inhibitor treatment on plasma oxytocin and cortisol in major depressive disorder
por: Keating, Charlotte, et al.
Publicado: (2013)

Maternal use of selective serotonin reuptake inhibitors during pregnancy is associated with Hirschsprung’s disease in newborns – a nationwide cohort study
por: Nielsen, Sebastian Werngreen, et al.
Publicado: (2017)

Enhanced Responsiveness to Selective Serotonin Reuptake Inhibitors during Lactation
por: Jury, Nicholas J., et al.
Publicado: (2015)

Authors' reply re: SSRI use during pregnancy and risk for postpartum hemorrhage: a national register‐based cohort study in Sweden
por: Skalkidou, A, et al.
Publicado: (2020)

Developmental Fluoxetine Exposure Normalizes the Long-Term Effects of Maternal Stress on Post-Operative Pain in Sprague-Dawley Rat Offspring
por: Knaepen, Liesbeth, et al.
Publicado: (2013)

Maternal occupational exposure and congenital heart defects in offspring
por: Spinder, Nynke, et al.
Publicado: (2020)

Effects of acute administration of selective serotonin reuptake inhibitors on sympathetic nerve activity
por: Tiradentes, R.V., et al.
Publicado: (2014)

Serotonin-Norepinephrine Reuptake Inhibitors for Pain Control: Premise and Promise
por: Marks, David M, et al.
Publicado: (2009)

Exposure to selective serotonin reuptake inhibitors and the risk of congenital malformations: a nationwide cohort study
por: Jimenez-Solem, Espen, et al.
Publicado: (2012)

Prenatal Selective Serotonin Reuptake Inhibitor Exposure, Depression, and Brain Morphology in Middle Childhood: Results From the ABCD Study
por: Moreau, Allison L., et al.
Publicado: (2022)

Gestational Exposure to Serotonin Reuptake Inhibitors and Pregnancy Outcome; Exploring the Role of Bias and Confounders
por: Koren, Gideon, et al.
Publicado: (2021)

Modulation of muscarinic system with serotonin-norepinephrine reuptake inhibitor antidepressant attenuates depression in mice
por: Singh, Paramdeep, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_d5mqrf45f1b0jfn5pqiqsoji1o